TRADING QUOTES 8:14 PM April 26, 2024
[stock-market-overview stockExchange="NYSENasdaq" width="600px" title="Isleworth Healthcare Acquisition Corp." equities="ISLEU;ISLE;ISLEW;" allowSort="true" includeChart="true" logoMaxHeight="20px" logoMaxWidth="90px" height="100%" culture="English-US"]
IPO Terms Details Business Combination Related Articles SEC Filings
SPAC Name : Isleworth Healthcare Acquisition Corp.
Total Public Proceeds at IPO($mm): 207.0
%Held in Trust: 100.0
$Held in Trust per Unit: $ 10.00
Mgmt's Sector Expertise/Focus: Healthcare
IPO Date: 2021-02-25
Months to Complete: 18
Deadline Date: 2022-09-01
Unit Structure (ISLEU)
Share (ISLE): 1 Share of Common Stock
Warrant (ISLEW) 1/2 Warrant
Right()
Public Warrant Terms:
Exercise Price: 11.500000000
Redemption Price: Cash/Cashless: $18.00
Redemption: Cash, Cashless or for Shares Mgmt's Discretion
Underwriters:
Book-runner(s): I-Bankers Securities, Inc.
Co-Manager(s): Dawson James Securities, Inc., Northland Capital Markets
Fees (Upfront/Deferred): 2%/---
Lawyers:
Issuer's Counsel: Schiff Hardin LLP
Underwriter's Counsel: Loeb & Loeb LLP
Additional Terms: Crescent term: $9.20 threshold, Limitation on redemption rights: 15%
SPAC Name: Isleworth Healthcare Acquisition Corp.
CURRENT FUNDS in TRUST: $211,476,566*
EST. PRO RATA AMOUNT IN TRUST: $10.01*
IMPLIED ENTERPRISE VALUE: 0
RECORD DATE: TBD
SHAREHOLDER VOTE DATE: TBD
SPAC NameSource: SEC.gov filings and SPAC Insider estimates

TRADING QUOTES       Business CombinationIPO Terms Details SPAC name: %spacname% CURRENT FUNDS in TRUST: $%ending_trust_ball%* EST. PRO RATA AMOUNT IN TRUST: $%implied_cash_per_share%* IMPLIED ENTERPRISE VALUE: %impliedenterprisevalue% RECORD DATE: %businesscombinationrecorddate% SHAREHOLDER VOTE DATE: %businesscombinationshareholdervotedate% Source: SEC.gov filings and SPAC Insider estimates SPAC name: %spacname% Total Public Proceeds at IPO ($mm): %total% % Held in Trust:
Read More

To access this page, you must purchase a database subscription via the Subscription Store Tab or log in.